Vaccine News and Research

Latest Vaccine News and Research

CureVac begins phase I study to assess intratumoral application of RNAdjuvant technology in patients with solid tumors

CureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced it has initiated a Phase I study assessing the intratumoral application of its novel RNAdjuvant technology in patients with superficial solid tumors that are easily accessible for repeated intratumoral injections. RNAdjuvant is designed to amplify the scope and quality of an immune response when used alone or in combination with other immune therapies.

28 Oct 2017

University of Colorado’s second shingles vaccine approved by FDA

The Centers for Disease Control's Advisory Committee on Immunization Practices recommended new treatment practices Wednesday for shingles based on a vaccine initially developed at the University of Colorado Health Sciences Center, now the University of Colorado Anschutz Medical Campus.

28 Oct 2017

Report reveals 84% drop in global measles deaths, but disease still kills 90 000 every year

In 2016, an estimated 90 000 people died from measles - an 84% drop from more than 550 000 deaths in 2000 - according to a new report published today by leading health organizations. This marks the first time global measles deaths have fallen below 100 000 per year.

27 Oct 2017

Novel molecule holds potential to become part of successful HIV vaccine

Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around HIV. The molecule could one day become part of a successful HIV vaccine.

27 Oct 2017

AACI, CDC, and ACS honor pediatricians who adopt effective HPV vaccination practices

Today the Association of American Cancer Institutes, the American Cancer Society, Inc., and the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases announced 10 award winners as part of its HPV Vaccine Is Cancer Prevention campaign.

27 Oct 2017

International initiative led by Vanderbilt aims to develop universal flu vaccine

Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.

27 Oct 2017

Mumps outbreak in U.S. necessitates third booster dose of vaccine for at-risk individuals

According to a federal experts panel yesterday (25th October 2017), a third dose of mumps vaccine is recommended when there is an outbreak of the viral disease. There have been several mumps outbreaks since 2006 in the United States, especially among students who have already been vaccinated before. Last year 6366 cases of the highly infectious viral infection were reported in the United States.

27 Oct 2017

Dream Team plans to stop pancreatic cancer before symptoms occur

Deeply entrenched and mature by the time it's found, pancreatic cancer is one of the hardest to defeat. A Dream Team assembled by Stand Up to Cancer and led by an investigator at The University of Texas MD Anderson Cancer Center will test new ways to find the disease in its emerging, more vulnerable phase in people who are at high risk for developing it.

26 Oct 2017

Education may help increase awareness of HPV risk and vaccination rates in college-age men

Male collegiate athletes have high rates of risk factors for infection with the cancer-causing human papillomavirus (HPV), but have low HPV vaccination rates and low awareness of their personal health risks, according to a study in the November issue of The Nurse Practitioner, published by Wolters Kluwer.

26 Oct 2017

Genetic variability of Helicobacter pylori complicates efforts to develop effective vaccine

Helicobacter pylori is a widespread bacterial pathogen that infects the lining of the stomach, where it can cause ulcers and even cancer. As a new study shows, its genetic variability complicates efforts to develop an effective vaccine.

25 Oct 2017

CDC recommends new vaccine for shingles

Last month a U.S. Food and Drug Administration (FDA) advisory panel had voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and efficacy of the vaccine and thus GlaxoSmithKline’s Shingrix.

25 Oct 2017

Direct application of immune cells accelerates healing of acute, chronic wounds in mice

A Massachusetts General Hospital research team has found a surprising potential solution to a persistent clinical problem - the healing of chronic wounds. In their report published in Wound Repair and Regeneration, the investigators from the MGH Vaccine and Immunotherapy Center describe how application of mature B lymphocytes - the immune cells best known for producing antibodies - greatly accelerated the healing of acute and chronic wounds in both diabetic and nondiabetic mice.

25 Oct 2017

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a novel way to genetically engineer T cells that may be effective for treating and preventing leukemia relapse.

25 Oct 2017

Study offers solution to protect against vaccine-enhanced respiratory disease

Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory disease that results when patients given an early form of a vaccine for respiratory syncytial virus (RSV) are exposed to RSV, according to a study led by Georgia State University.

23 Oct 2017

New study explores how herpes simplex virus may change during familial transmission

A new study explores how herpes simplex virus might change when passed from one individual to another, information that may prove useful in future development of therapeutics and vaccines.

20 Oct 2017

New vaccine for pneumonia holds promise to save thousands of lives

In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million.

20 Oct 2017

HPV-related oropharyngeal cancer risk remains generally low, study suggests

The prevalence of throat (oropharyngeal) cancers caused by the human papilloma virus (HPV) has increased in recent decades, and some groups are much more likely than others to have the oral HPV infections that can cause these cancers.

20 Oct 2017

WHO supports Nigerian Government’s immunization efforts against yellow fever

The Government of Nigeria has launched a campaign to immunize 873 837 people against yellow fever in the states of Kwara and Kogi.

19 Oct 2017

One ninth of men in the US are infected with oral HPV, study shows

Around one in nine men in the US. are infected with oral human papillomavirus (HPV), according to a study led by researchers at the University of Florida.

18 Oct 2017

Vaccinated pediatric cancer patients just as likely as unvaccinated peers to develop flu

Young leukemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals. These findings from the St. Jude Children's Research Hospital study appear October 16, 2017, in the Journal of Pediatrics.

16 Oct 2017

Vaccine News and Research

Latest Vaccine News and Research

CureVac begins phase I study to assess intratumoral application of RNAdjuvant technology in patients with solid tumors

University of Colorado’s second shingles vaccine approved by FDA

Report reveals 84% drop in global measles deaths, but disease still kills 90 000 every year

Novel molecule holds potential to become part of successful HIV vaccine

AACI, CDC, and ACS honor pediatricians who adopt effective HPV vaccination practices

International initiative led by Vanderbilt aims to develop universal flu vaccine

Mumps outbreak in U.S. necessitates third booster dose of vaccine for at-risk individuals

Dream Team plans to stop pancreatic cancer before symptoms occur

Education may help increase awareness of HPV risk and vaccination rates in college-age men

Genetic variability of Helicobacter pylori complicates efforts to develop effective vaccine

CDC recommends new vaccine for shingles

Direct application of immune cells accelerates healing of acute, chronic wounds in mice

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Study offers solution to protect against vaccine-enhanced respiratory disease

New study explores how herpes simplex virus may change during familial transmission

New vaccine for pneumonia holds promise to save thousands of lives

HPV-related oropharyngeal cancer risk remains generally low, study suggests

WHO supports Nigerian Government’s immunization efforts against yellow fever

One ninth of men in the US are infected with oral HPV, study shows

Vaccinated pediatric cancer patients just as likely as unvaccinated peers to develop flu

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in